Last reviewed · How we verify

NCT07471750

Acquisition and Clinical Image Evaluation of Fujifilm's High Resolution (HR) Digital Breast Tomosynthesis (DBT) Images.

Not yet recruiting NA Last updated 16 March 2026
What this trial tests

NA trial testing DBT HR mode image acquisition in Routine Screening Mammography in 18 participants. Not yet recruiting.

Timeline
30 March 2026
Primary endpoint
15 May 2026
1 June 2026

Quick facts

Lead sponsorFujifilm Medical Systems USA, Inc.
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposescreening
Enrollment18
Start date30 March 2026
Primary completion15 May 2026
Estimated completion1 June 2026

Drugs / interventions tested

Conditions studied

Sponsor

Fujifilm Medical Systems USA, Inc. — full company profile →

Who can join

40 and older, female only, with Routine Screening Mammography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acquisition and clinical image evaluation of Fujifilm High Resolution (HR) Digital Breast Tomosynthesis (DBT) images.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Fujifilm Medical Systems USA, Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07471750.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing